Memantine ‐induced bradycardia – a rare adverse reaction

Behavioural and psychological symptoms of dementia, such as aggression or agitation are very frequent in Alzheimer's disease with most guidelines recommending memantine as first‐line pharmacological treatment. Here, the authors describe a patient who developed bradycardia when prescribed memantine and the subsequent changes required to her medication management to avoid further cardiac adverse reactions.

Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Georgios Mousailidis, Shafalica Bhan ‐Kotwal, Carlo Lazzari, Ahmed Shoka Tags: Case notes Source Type: research